Notes
low density lipoprotein cholesterol
National Health Service
Reference
NICE. NICE issues draft guidance on alirocumab for lipid disorder. Media Release : 8 Feb 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE draft guidance on alirocumab: not recommended. PharmacoEcon Outcomes News 746, 32 (2016). https://doi.org/10.1007/s40274-016-2810-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2810-1